Skip to content
Review Open access

O-linked β-N-acetylglucosamine homeostasis in brain health and disease: From physiology to neurodevelopmental and neurodegenerative disorders.

Oct 2026 · Neural Regeneration Research · 0 citations
Medicine

TL;DR

O-linked β-N-acetylglucosamine signaling is highlighted as a molecular bridge connecting early brain development, adulthood, and aging, providing an integrated framework for understanding brain physiology and disease.

Abstract

ABSTRACT Protein O-GlcNAcylation is a dynamic and reversible post-translational modification that functions as a central nutrient-sensing mechanism linking cellular metabolism to protein function. Controlled by the opposing activities of O-linked β-N-acetylglucosamine transferase and O-GlcNAcase, O-GlcNAcylation regulates thousands of nuclear, cytoplasmic, synaptic, and mitochondrial proteins involved in gene expression, neuronal differentiation, synaptic plasticity, proteostasis, mitochondrial homeostasis, and neuroimmune signaling. The brain exhibits particularly high O-linked β-N-acetylglucosamine activity, reflecting its exceptional metabolic demands and the need to rapidly couple nutrient availability with neuronal function. Emerging evidence demonstrates that precise regulation of O-linked β-N-acetylglucosamine cycling is indispensable throughout the lifespan, from embryonic neurodevelopment to healthy brain aging. Conversely, disruption of O-linked β-N-acetylglucosamine homeostasis caused by genetic defects, metabolic disturbances, or environmental stress contributes to neurodevelopmental disorders. In the aging brain, impaired glucose metabolism and insulin resistance reduce O-GlcNAcylation, promoting mitochondrial dysfunction, neuroinflammation, proteostasis failure, and the accumulation of pathogenic proteins. Consequently, dysregulated O-linked β-N-acetylglucosamine signaling has emerged as a convergent mechanism underlying brain disorders spanning neurodevelopment to neurodegeneration. Although clinical translation remains challenging, growing evidence supports O-GlcNAcylation as a master regulator of brain homeostasis and a promising therapeutic target for neurological disorders. Collectively, this review highlights O-linked β-N-acetylglucosamine signaling as a molecular bridge connecting early brain development, adulthood, and aging, providing an integrated framework for understanding brain physiology and disease.

Read PDF

Similar papers

Review Sep 2026

Decoding SUMOylation as a metabolic stress sensor in aging and age-related disorders: mechanisms, tissue specificity and therapeutic potential.

This synthesis provides a framework for understanding how SUMOylation links metabolic stress to tissue-specific aging trajectories and therapeutic potential and evaluates emerging translational approaches that highlight both the opportunities and challenges of targeting SUMO-regulated stress responses in aging.

Xin-Yue Liu, Shuang Chen, Dong-Can Liu et al. · 0 citations
Open access Oct 2026

Overexpression of endoplasmic reticulum acetyl-CoA transporter AT-1 alters neuronal metabolism, growth, and synaptic activity

It is shown that AT-1 overexpression impacts diverse phenotypes related to neuronal function and plasticity, and metabolic adaptation was coincident with decreased synaptic activity, indicating that neuronal communication is coordinated, in part, through acetyl-CoA metabolism.

Eric R. McGregor, C. McGill, N. Arp et al. · 0 citations
Open access Oct 2026

Disrupted O-GlcNAc homeostasis links microglial dysfunction to cerebellar hypoplasia

Pathogenic variants in O-GlcNAc transferase, which catalyses nucleocytoplasmic protein O-GlcNAcylation, cause a neurodevelopmental disorder (OGT-NDD) characterised by intellectual disability and motor impairments. However, mechanisms linking O-GlcNAc dyshomeostasis to brain development remain unclear. Longitudinal neur...

S. Almeida, S. Balasubramaniam, A. Jusiel et al. · 0 citations
Review Open access Oct 2026

ER-Nε-lysine acetylation machinery in neurological disorders: A context-dependent regulator of proteostasis.

Despite extensive characterization of cytosolic and nuclear acetylation, the functional relevance of luminal ER-Nε-lysine acetylation in the nervous system remains poorly understood. This modification is mediated by a coordinated metabolic-secretory axis involving acetyl-CoA availability and the ER-resident acetyltrans...

Emanuele Di Martino, R. A. de Vos, Sofia Koenig Gimeno et al. · 0 citations
Open access Oct 2026

Effects of Pharmacologically Induced Hyper-Protein O-GlcNAcylation on the Heart Transcriptome

Background/Objectives: O-GlcNAcylation is a post-translational modification affecting diverse cell functions, including transcriptional regulation. Aberrant levels of protein O-GlcNAcylation have been observed in neurodegenerative and cardiovascular diseases. We have previously demonstrated that systemic elevation of p...

Margaret B. Bell, Gloria A. Benavides, Xiao-Sen Ouyang et al. · 0 citations
Review Open access Sep 2026

Hexokinase-2-glycolytic overload axis in brain disorders exacerbated by diabetes.

Subjects with diabetes have an increased risk of dementia, Parkinson's disease, and stroke. In the central nervous system, there is increased inflammation, blood-brain barrier permeability, amyloid-β and α-synuclein deposition, and decreased neuronal synaptogenesis and survival. The role of hexokinases in controlling g...

M. Alhujaily, N. Rabbani, Paul J Thornalley · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.